TABLE OF CONTENTS
- Introduction
- Definition of Patient Positioning Systems Market
- Scope of the Report
- Methodology
- Executive Summary
- Market Overview
- Market Definition and Segmentation
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Porter's Five Forces Analysis
- PESTEL Analysis
- Patient Positioning Systems Market, by product
- Tables
- Surgical Table
- Radiolucent Imaging Table
- Examination Table
- Accessories
- Radiotherapy Immobilization/ Fixation Products
- Other Accessories
- Other Patient Positioning System
- Tables
- Patient positioning system Market, by Application
- Surgery
- Disease Diagnosis
- Cancer Therapy
- Patient positioning system Market, by end user
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Other End Users
- Patient positioning system Market, by Geography
- North America
- United States
- Canada
- Europe
- United Kingdom
- Germany
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of Middle East & Africa
- North America
- Competitive Landscape
- Company Profiles
- Span America.
- Company Overview
- Product Portfolio and Description
- Key Highlights
- Financial Overview
- GF Health Products
- Medifa-HesseGmbh& Co. KG
- Gendron Inc.
- Guangzhou Renfu Medical Equipment Co, Ltd
- Famed Zywiec Sp. Z O.O.
- Smith & Nephew Plc
- Stryker Corporation
- Hill-Rom Holdings, Inc.
- Getinge Ab
- Merivaara Corp.
- Orfit Industries
- Medline Industries
- Oncology Systems Limited.
- Paramount Bed Co., Ltd.
- Mediland Enterprise Corporation
- Innovative Medical Products Inc.
- OPT Surgisystems S.R.L.
- Leoni AG
- Xodus Medical Inc.
- Steris Plc
- Eschmann Technologies Ltd.
- Mizuho OSI
- ALVO Medical
- Civco Radiotherapy
- Probed Medical Technologies Inc.
- Oncotech
- Elekta AB
- Medtronic
- C-RAD
- Span America.
- Conclusion and Future Outlook
- Appendix
- Research Methodology
- About the Pharmanucleus
12. Disclaimer